INVESTABOT
Equity Research
XNYS · SERVICES-MEDICAL LABORATORIES
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-08-11. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-08-17. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
TL;DR: Megan D. Bailey is stepping down as Executive Vice President and President of Central Laboratories and International at Labcorp Holdings, effective September 4, 2026. Her successor is already named, suggesting an…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-08-04. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-05-11. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-05-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Labcorp Holdings (LH) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 4 unique sellers · 9 accumulating - 3 trimming - 1 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 1, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | GRANT | 750 | — | — |
| September 1, 2026 | Meltzer Jonathan C | EVP, COO | GRANT | 900 | — | — |
| September 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | GRANT | 1,500 | — | — |
| September 1, 2026 | Caveney Brian J | EVP, Pres of BLS, CMO & CSO | GRANT | 3,000 | — | — |
| August 17, 2026 | Anderson Kerrii B | — | SELL | -3,000 | $318 | ~$1.0M |
| August 11, 2026 | Schechter Adam H | President & CEO | SELL | -4,669 | $320 | ~$1.5M |
| August 4, 2026 | Summy Amy B. | EVP, Chief Marketing Officer | SELL | -924 | $307 | ~$0.3M |
| August 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | SELL | -82 | $309 | ~$25K |
| August 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | OPTION_EXERCISE | 1,338 | $209 | ~$0.3M |
| August 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | SELL | -1,338 | $309 | ~$0.4M |
| August 3, 2026 | Wilkinson Peter J | SVP, Chief Accounting Officer | OPTION_EXERCISE | -1,338 | — | — |
| July 2, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | SELL | -92 | $286 | ~$26K |
| July 2, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | SELL | -234 | $286 | ~$67K |
| July 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | OPTION_EXERCISE | 256 | — | — |
| July 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | TAX_WITHHOLD | -73 | $284 | ~$21K |
| July 1, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | OPTION_EXERCISE | -256 | — | — |
| July 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | OPTION_EXERCISE | 327 | — | — |
| July 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | TAX_WITHHOLD | -93 | $284 | ~$26K |
| July 1, 2026 | Vaughn Bryan T | EVP and President, Diagnostics | OPTION_EXERCISE | -327 | — | — |
| June 8, 2026 | Kyle Kathryn W | EVP, Chief Legal Officer | SELL | -762 | $264 | ~$0.2M |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| August 17, 2026 | Kerrii B Anderson | — | 3,000 | SEC |
| August 11, 2026 | Schechter Adam H | — | 4,669 | SEC |
| August 4, 2026 | Summy Amy B. | — | 924 | SEC |
| July 2, 2026 | Vaughn Bryan T | — | 234 | SEC |
| July 2, 2026 | Kyle Kathryn W | — | 92 | SEC |
| July 1, 2026 | van der Vaart Sandra D | — | 7,138 | SEC |
| June 8, 2026 | Kyle Kathryn W | — | 762 | SEC |
| May 11, 2026 | Schechter Adam H | — | 5,903 | SEC |
| May 6, 2026 | van der Vaart Sandra D | — | 6,238 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 9,850,631 | ~$2.5B | — | January 29, 2026 |
| BlackRock | 9,493,144 | ~$1.9B | — | August 13, 2024 |
| BlackRock | 6,574,261 | ~$1.8B | 2.0% | August 7, 2026 |
| BlackRock | 6,444,856 | ~$1.7B | -1.5% | May 13, 2026 |
| BlackRock | 6,540,781 | ~$1.6B | — | February 12, 2026 |
| State Street | 3,907,656 | ~$1.1B | 1.1% | August 7, 2026 |
| State Street | 3,863,171 | ~$1.0B | 1.0% | May 15, 2026 |
| State Street | 3,826,327 | ~$959.9M | — | February 13, 2026 |
| Fidelity (FMR) | 1,904,870 | ~$533.4M | 47.9% | August 13, 2026 |
| Morgan Stanley | 1,609,447 | ~$450.6M | 7.4% | August 13, 2026 |
| JP Morgan Chase | 1,532,723 | ~$404.0M | 19.1% | May 13, 2026 |
| Morgan Stanley | 1,498,027 | ~$399.7M | -0.5% | May 15, 2026 |
| Morgan Stanley | 1,505,539 | ~$377.7M | — | May 27, 2026 |
| JP Morgan Chase | 1,268,384 | ~$354.6M | -17.3% | August 12, 2026 |
| Fidelity (FMR) | 1,288,411 | ~$343.8M | -3.8% | May 15, 2026 |
| Fidelity (FMR) | 1,339,745 | ~$336.1M | — | February 17, 2026 |
| JP Morgan Chase | 1,287,177 | ~$322.9M | — | February 11, 2026 |
| Goldman Sachs | 595,504 | ~$149.4M | — | March 25, 2026 |
| Goldman Sachs | 435,456 | ~$121.9M | 10.0% | August 14, 2026 |
| Goldman Sachs | 395,998 | ~$105.7M | -33.5% | May 15, 2026 |